Pharma plants are awash in data. There are myriad sources: MES for execution status, LIMS (QC results), process historians (equipment conditions), QMS (quality/deviations) to name just a few, but release decisions still stall when those sources disagree or lack an owner. To deal with the chaos, eschbach’s visual factory centers daily work on SQDCP boards…
Answering the CDMO shortage: A new paradigm for drug development
What can the pharma industry do about the critical shortage of contract manufacturing organization (CMO) and contract development and manufacturing company (CDMO) facilities? For a growing number of young entrepreneurial drug companies, the answer is a middle ground between building their own facilities and outsourcing to the saturated CMO/CDMO market. This middle ground lies in…